{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:34:08Z","timestamp":1788618848565,"version":"build-2803163510"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Sodium\u2013glucose cotransporter 2 (SGLT2), also known as solute carrier family 5 member 2 (SLC5A2), is a promising target for a new class of drugs primarily established as kidney-targeting, effective glucose-lowering agents used in diabetes mellitus (DM) patients. Increasing evidence indicates that besides renal effects, SGLT2 inhibitors (SGLT2i) have also a systemic impact via indirectly targeting the heart and other tissues. Our hypothesis states that the pleiotropic effects of SGLT2i are associated with their binding force, location of targets in the SGLT2 networks, targets involvement in signaling pathways, and their tissue-specific expression.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Thus, to investigate differences in SGLT2i impact on human organisms, we re-created the SGLT2 interaction network incorporating its inhibitors and metformin and analyzed its tissue-specific expression using publicly available datasets. We analyzed it in the context of the so-called key terms ( autophagy, oxidative stress, aging, senescence, inflammation, AMPK pathways, and mTOR pathways) which seem to be crucial to elucidating the SGLT2 role in a variety of clinical manifestations.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Analysis of SGLT2 and its network components\u2019 expression confidence identified selected organs in the following order: kidney, liver, adipose tissue, blood, heart, muscle, intestine, brain, and artery according to the TISSUES database. Drug repurposing analysis of known SGLT2i pointed out the influence of SGLT1 regulators on the heart and intestine tissue. Additionally, dapagliflozin seems to also have a stronger impact on brain tissue through the regulation of SGLT3 and SLC5A11. The shortest path analysis identified interaction SIRT1-SGLT2 among the top five interactions across six from seven analyzed networks associated with the key terms. Other top first-level SGLT2 interactors associated with key terms were not only ADIPOQ, INS, GLUT4, ACE, and GLUT1 but also less recognized ILK and ADCY7. Among other interactors which appeared in multiple shortest-path analyses were GPT, COG2, and MGAM. Enrichment analysis of SGLT2 network components showed the highest overrepresentation of hypertensive disease, DM-related diseases for both levels of SGLT2 interactors. Additionally, for the extended SGLT2 network, we observed enrichment in obesity (including SGLT1), cancer-related terms, neuroactive ligand\u2013receptor interaction, and neutrophil-mediated immunity.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study provides comprehensive and ranked information about the SGLT2 interaction network in the context of tissue expression and can help to predict the clinical effects of the SGLT2i.<\/jats:p>","DOI":"10.3389\/fphar.2022.901340","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T08:29:08Z","timestamp":1660552148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Zofia","family":"Wicik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jarosz-Popek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Wolska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Eyileten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta M.","family":"Siller-Matula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"von Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Filipiak\u202c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Postu\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"902","DOI":"10.5551\/jat.1933","article-title":"Usefulness of GPT for Diagnosis of Metabolic Syndrome in Obese Japanese Children","volume":"16","author":"Abe","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.4317\/jced.52329","article-title":"Salivary Gland Dysfunction Markers in Type 2 Diabetes Mellitus Patients","volume":"7","author":"Aitken-Saavedra","year":"2015","journal-title":"J. Clin. Exp. Dent."},{"key":"B3","doi-asserted-by":"publisher","first-page":"657873","DOI":"10.3389\/fendo.2021.657873","article-title":"CRISPR\/Cas9 ADCY7 Knockout Stimulates the Insulin Secretion Pathway Leading to Excessive Insulin Secretion","volume":"12","author":"Alhaidan","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"13009","DOI":"10.1038\/s41598-019-49525-y","article-title":"Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"9","author":"Bae","year":"2019","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.2337\/db20-0636","article-title":"A Computational Approach for Defining a Signature of \u03b2-Cell Golgi Stress in Diabetes","volume":"69","author":"Bone","year":"2020","journal-title":"Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tig.2013.08.003","article-title":"LongevityMap: A Database of Human Genetic Variants Associated with Longevity","volume":"29","author":"Budovsky","year":"2013","journal-title":"Trends Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1098\/rstb.2005.1763","article-title":"Glucose-sensing Neurons of the Hypothalamus","volume":"360","author":"Burdakov","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e98720","DOI":"10.1172\/jci.insight.98720","article-title":"SGLT2 Inhibitor Dapagliflozin Limits Podocyte Damage in Proteinuric Nondiabetic Nephropathy","volume":"3","author":"Cassis","year":"2018","journal-title":"JCI Insight"},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR Tissue Expression Profiling of the Human SGLT2 Gene and Related Family Members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: Interactive and Collaborative HTML5 Gene List Enrichment Analysis Tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-511X-6-35","article-title":"Gene Expression Profile in Obesity and Type 2 Diabetes Mellitus","volume":"6","author":"Das","year":"2007","journal-title":"Lipids Health Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fphar.2014.00218","article-title":"Analysis of the Efficacy of SGLT2 Inhibitors Using Semi-mechanistic Model","volume":"5","author":"Demin","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J. Proteome Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2019.01.002","article-title":"SGLT2 Inhibitors and Metformin: Dual Antihyperglycemic Therapy and the Risk of Metabolic Acidosis in Type 2 Diabetes","volume":"846","author":"Donnan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping Identifiers for the Integration of Genomic Datasets with the R\/Bioconductor Package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat. Protoc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"691907","DOI":"10.3389\/fcvm.2021.691907","article-title":"Cardiovascular Outcome in Patients Treated with SGLT2 Inhibitors for Heart Failure: A Meta-Analysis","volume":"8","author":"Gager","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2147\/dmso.s212715","article-title":"SGLT-2 Inhibitors as Promising Therapeutics for Non-alcoholic Fatty Liver Disease: Pathophysiology, Clinical Outcomes, and Future Directions","volume":"12","author":"Gharaibeh","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","article-title":"Physiology of Renal Glucose Handling via SGLT1, SGLT2 and GLUT2","volume":"61","author":"Ghezzi","year":"2018","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.12688\/f1000research.9909.1","article-title":"The PathLinker App: Connect the Dots in Protein Interaction Networks","volume":"6","author":"Gil","year":"2017","journal-title":"F1000Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"D507","DOI":"10.1093\/nar\/gkq968","article-title":"The BRENDA Tissue Ontology (BTO): The First All-Integrating Ontology of All Organisms for Enzyme Sources","volume":"39","author":"Gremse","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"bqab079","DOI":"10.1210\/endocr\/bqab079","article-title":"SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases","volume":"162","author":"Hoong","year":"2021","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12887-021-02922-7","article-title":"Component of Oligomeric Golgi Complex 1 Deficiency Leads to Hypoglycemia: A Case Report and Literature Review","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2013.03.015","article-title":"Redox Regulation of SIRT1 in Inflammation and Cellular Senescence","volume":"61","author":"Hwang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.3390\/ijms20205237","article-title":"The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma","volume":"20","author":"Jojima","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10741-017-9665-9","article-title":"Direct Cardiovascular Impact of SGLT2 Inhibitors: Mechanisms and Effects","volume":"23","author":"Kaplan","year":"2018","journal-title":"Heart fail. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes with Cardiovascular Disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s00125-021-05498-0","article-title":"Dapagliflozin Reduces Thrombin Generation and Platelet Activation: Implications for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus","volume":"64","author":"Kohlmorgen","year":"2021","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"F1263","DOI":"10.1152\/ajprenal.00475.2009","article-title":"Troglitazone Ameliorates High Glucose-Induced EMT and Dysfunction of SGLTs through PI3K\/Akt, GSK-3\u03b2, Snail1, and \u03b2-catenin in Renal Proximal Tubule Cells","volume":"298","author":"Lee","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1681\/ASN.2008090930","article-title":"Inhibition of Integrin-Linked Kinase Attenuates Renal Interstitial Fibrosis","volume":"20","author":"Li","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: A Web-Accessible Database of Experimentally Determined Protein-Ligand Binding Affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"25758","DOI":"10.1074\/jbc.M112.362343","article-title":"NAD+-dependent Sirtuin 1 and 6 Proteins Coordinate a Switch from Glucose to Fatty Acid Oxidation during the Acute Inflammatory Response","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-Of-The-Art Review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10557-021-07186-y","article-title":"A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology","volume":"36","author":"Mai","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin Inhibits Interleukin-1\u03b2-Stimulated Cytokine and Chemokine Secretion in Vascular Endothelial Cells by AMP-Activated Protein Kinase-dependent and -independent Mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin Use and All-Cause and Prostate Cancer-specific Mortality Among Men with Diabetes","volume":"31","author":"Margel","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"113076","DOI":"10.1016\/j.expneurol.2019.113076","article-title":"GluT4: A Central Player in Hippocampal Memory and Brain Insulin Resistance","volume":"323","author":"McNay","year":"2020","journal-title":"Exp. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/0091270008316885","article-title":"Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients with Mild to Moderate Hypertension","volume":"48","author":"Mistry","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/CS20171298","article-title":"SGLT2 Inhibition and Kidney Protection","volume":"132","author":"Nespoux","year":"2018","journal-title":"Clin. Sci. (Lond)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.120.051783","article-title":"Effect of Empagliflozin on the Clinical Stability of Patients with Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-020-01041-4","article-title":"Autophagy-dependent and -independent Modulation of Oxidative and Organellar Stress in the Diabetic Heart by Glucose-Lowering Drugs","volume":"19","author":"Packer","year":"","journal-title":"Cardiovasc. Diabetol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ejhf.1732","article-title":"Autophagy Stimulation and Intracellular Sodium Reduction as Mediators of the Cardioprotective Effect of Sodium-Glucose Cotransporter 2 Inhibitors","volume":"22","author":"Packer","year":"","journal-title":"Eur. J. Heart Fail"},{"key":"B47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/dom.13961","article-title":"Interplay of Adenosine Monophosphate-Activated Protein Kinase\/sirtuin-1 Activation and Sodium Influx Inhibition Mediates the Renal Benefits of Sodium-Glucose Co-transporter-2 Inhibitors in Type 2 Diabetes: A Novel Conceptual Framework","volume":"22","author":"Packer","year":"","journal-title":"Diabetes Obes. Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dci19-0074","article-title":"SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action","volume":"43","author":"Packer","year":"","journal-title":"Diabetes Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e007197","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective Effects of Sirtuin-1 and its Downstream Effectors: Potential Role in Mediating the Heart Failure Benefits of SGLT2 (Sodium-glucose Cotransporter 2) Inhibitors","volume":"13","author":"Packer","year":"","journal-title":"Circ. Heart Fail"},{"key":"B50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/cvr\/cvaa064","article-title":"Critical Examination of Mechanisms Underlying the Reduction in Heart Failure Events with SGLT2 Inhibitors: Identification of a Molecular Link between Their Actions to Stimulate Erythrocytosis and to Alleviate Cellular Stress","volume":"117","author":"Packer","year":"","journal-title":"Cardiovasc. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jchf.2021.05.019","article-title":"Differential Pathophysiological Mechanisms in Heart Failure with a Reduced or Preserved Ejection Fraction in Diabetes","volume":"9","author":"Packer","year":"","journal-title":"JACC Heart Fail"},{"key":"B52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s41061-019-0243-6","article-title":"In the Search of Glycoside-Based Molecules as Antidiabetic Agents","volume":"377","author":"Pa\u0142asz","year":"2019","journal-title":"Top. Curr. Chem. (Z)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"bay003","DOI":"10.1093\/database\/bay028","article-title":"TISSUES 2.0: An Integrative Web Resource on Mammalian Tissue Expression","volume":"2018","author":"Palasca","year":"2018","journal-title":"Database"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e54442","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?","volume":"8","author":"Panchapakesan","year":"2013","journal-title":"PLoS ONE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A Novel Paradigm for Heart Failure with Preserved Ejection Fraction: Comorbidities Drive Myocardial Dysfunction and Remodeling through Coronary Microvascular Endothelial Inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"F449","DOI":"10.1152\/ajprenal.00431.2018","article-title":"Unraveling Reno-Protective Effects of SGLT2 Inhibition in Human Proximal Tubular Cells","volume":"316","author":"Pirklbauer","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2340\/00015555-0650","article-title":"Drug-induced Pruritus: A Review","volume":"89","author":"Reich","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db16-0917","article-title":"Brain GLUT4 Knockout Mice Have Impaired Glucose Tolerance, Decreased Insulin Sensitivity, and Impaired Hypoglycemic Counterregulation","volume":"66","author":"Reno","year":"2017","journal-title":"Diabetes"},{"key":"B59","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic Insights of Empagliflozin in Nondiabetic Patients with HFrEF: From the EMPA-TROPISM Study","volume":"9","author":"Requena-Ib\u00e1\u00f1ez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00125-018-4654-7","article-title":"Development of SGLT1 and SGLT2 Inhibitors","volume":"61","author":"Rieg","year":"2018","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"E1028","DOI":"10.1152\/ajpendo.00395.2010","article-title":"SGLT1 Protein Expression in Plasma Membrane of Acinar Cells Correlates with the Sympathetic Outflow to Salivary Glands in Diabetic and Hypertensive Rats","volume":"299","author":"Sabino-Silva","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/14656566.2020.1776262","article-title":"An Emerging New Concept for the Management of Type 2 Diabetes with a Paradigm Shift from the Glucose-Centric to Beta Cell-Centric Concept of Diabetes-An Asian Perspective","volume":"21","author":"Saisho","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"B63","doi-asserted-by":"publisher","first-page":"937","DOI":"10.7150\/ijms.22224","article-title":"Susceptibility to Serious Skin and Subcutaneous Tissue Disorders and Skin Tissue Distribution of Sodium-dependent Glucose Co-transporter Type 2 (SGLT2) Inhibitors","volume":"15","author":"Sakaeda","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12933-020-01141-1","article-title":"Characterization of Left Ventricular Myocardial Sodium-Glucose Cotransporter 1 Expression in Patients with End-Stage Heart Failure","volume":"19","author":"Sayour","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nrendo.2017.154","article-title":"Diabetes: Metformin-A Cardiovascular Moderator of DPP4 Inhibitors?","volume":"14","author":"Scheen","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/0148607104028005364","article-title":"The Glucose Transporter Families SGLT and GLUT: Molecular Basis of Normal and Aberrant Function","volume":"28","author":"Scheepers","year":"2004","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New Insights into the Role of mTOR Signaling in the Cardiovascular System","volume":"122","author":"Sciarretta","year":"","journal-title":"Circ. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The Role of Autophagy in the Heart","volume":"80","author":"Sciarretta","year":"","journal-title":"Annu. Rev. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.2337\/dc17-0299","article-title":"Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135","volume":"40","author":"Sonne","year":"2017","journal-title":"Diabetes Care"},{"key":"B71","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.eururo.2012.12.004","article-title":"Metformin and Prostate Cancer: Reduced Development of Castration-Resistant Disease and Prostate Cancer Mortality","volume":"63","author":"Spratt","year":"2013","journal-title":"Eur. Urol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e14090","DOI":"10.14814\/phy2.14090","article-title":"Sigmoidal Kinetics Define Porcine Intestinal Segregation of Electrogenic Monosaccharide Transport Systems as Having Multiple Transporter Population Involvement","volume":"7","author":"Subramaniam","year":"2019","journal-title":"Physiol. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/metabo11020087","article-title":"The Effects of SGLT2 Inhibitors on Lipid Metabolism","volume":"11","author":"Szekeres","year":"2021","journal-title":"Metabolites"},{"key":"B74","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkx1042","article-title":"Human Ageing Genomic Resources: New and Updated Databases","volume":"46","author":"Tacutu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e019463","DOI":"10.1161\/JAHA.120.019463","article-title":"Effects of Sodium\/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials","volume":"10","author":"Teo","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"B76","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1038\/s41598-018-25054-y","article-title":"High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection","volume":"8","author":"Umino","year":"2018","journal-title":"Sci. Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"41166","DOI":"10.1038\/srep41166","article-title":"Sodium-myoinositol Cotransporter-1, SMIT1, Mediates the Production of Reactive Oxygen Species Induced by Hyperglycemia in the Heart","volume":"7","author":"Van Steenbergen","year":"2017","journal-title":"Sci. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The Diabetes Medication Canagliflozin Reduces Cancer Cell Proliferation by Inhibiting Mitochondrial Complex-I Supported Respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"B79","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 Protein Inhibition Decreases Renal Lipid Accumulation, Inflammation, and The Development of Nephropathy in Diabetic Mice","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11934-017-0693-8","article-title":"Metformin and Prostate Cancer: A New Role for an Old Drug","volume":"18","author":"Whitburn","year":"2017","journal-title":"Curr. Urol. Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ygeno.2020.09.041","article-title":"The Crosstalk between Bone Metabolism, lncRNAs, microRNAs and mRNAs in Coronary Artery Calcification","volume":"113","author":"Wicik","year":"2021","journal-title":"Genomics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.119.11684","article-title":"Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors","volume":"75","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"B83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating Neutropenia and Neutrophil Dysfunction in Glycogen Storage Disease Type Ib with an SGLT2 Inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of Human Sodium Glucose Transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol. Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.34067\/KID.0002772021","article-title":"SGLT2 Inhibitors: Physiology and Pharmacology","volume":"2","author":"Wright","year":"2021","journal-title":"Kidney360"},{"key":"B87","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/a-0958-2441","article-title":"Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes","volume":"51","author":"Wu","year":"2019","journal-title":"Horm. Metab. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.canlet.2020.09.005","article-title":"An SGLT2 Inhibitor Modulates SHH Expression by Activating AMPK to Inhibit the Migration and Induce the Apoptosis of Cervical Carcinoma Cells","volume":"495","author":"Xie","year":"2020","journal-title":"Cancer Lett."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/bph.15381","article-title":"Inhibition of the Sodium-Glucose Co-transporter SGLT2 by Canagliflozin Ameliorates Diet-Induced Obesity by Increasing Intra-adipose Sympathetic Innervation","volume":"178","author":"Yang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1111\/jcmm.16786","article-title":"Effect of Dapagliflozin on Diabetic Patients with Cardiovascular Disease via MAPK Signaling Pathway","volume":"25","author":"Yue","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"711242","DOI":"10.3389\/fchem.2021.711242","article-title":"Targeting N-Terminal Human Maltase-Glucoamylase to Unravel Possible Inhibitors Using Molecular Docking, Molecular Dynamics Simulations, and Adaptive Steered Molecular Dynamics Simulations","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.ajpath.2016.03.015","article-title":"\u03b13 Integrin of Cell-Cell Contact Mediates Kidney Fibrosis by Integrin-Linked Kinase in Proximal Tubular E-Cadherin Deficient Mice","volume":"186","author":"Zheng","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"110821","DOI":"10.1016\/j.biopha.2020.110821","article-title":"Sodium-glucose Co-transporter-2 (SGLT-2) Inhibition Reduces Glucose Uptake to Induce Breast Cancer Cell Growth Arrest through AMPK\/mTOR Pathway","volume":"132","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.901340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T08:29:12Z","timestamp":1660552152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.901340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":93,"alternative-id":["10.3389\/fphar.2022.901340"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.901340","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"901340"}}